Dynamic Medical Technologies Inc. (TPEX:4138)
Taiwan · Delayed Price · Currency is TWD 50.60
-0.10 (-0.20%)
May 29, 2026, 1:30 PM CST
TPEX:4138 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,378 | 1,387 | 1,573 | 1,594 | 1,292 | 1,028 |
| 1,378 | 1,387 | 1,573 | 1,594 | 1,292 | 1,028 | |
Revenue Growth (YoY) | -9.37% | -11.82% | -1.31% | 23.36% | 25.63% | 1.87% |
Cost of Revenue | 771.35 | 775.36 | 943.48 | 990.45 | 839.16 | 673.6 |
Gross Profit | 606.95 | 611.4 | 629.22 | 603.05 | 452.53 | 354.58 |
Selling, General & Admin | 428.46 | 425.79 | 383.28 | 337.43 | 297.04 | 192.89 |
Operating Expenses | 424.35 | 421.41 | 384.13 | 334.5 | 294.2 | 194.16 |
Operating Income | 182.6 | 189.99 | 245.09 | 268.56 | 158.33 | 160.42 |
Interest Expense | - | - | -1.75 | -0.15 | -1.33 | -0.87 |
Interest & Investment Income | 39.53 | 41.54 | 37.62 | 27.75 | 14.11 | 6.98 |
Earnings From Equity Investments | -0.11 | -1.44 | 1.05 | 1.05 | -2.6 | 0.86 |
Currency Exchange Gain (Loss) | -11.3 | -11.3 | 5.52 | 1.3 | 7 | -0.59 |
Other Non Operating Income (Expenses) | -6.64 | -0.79 | -2.79 | -1.22 | 2.64 | 7.04 |
EBT Excluding Unusual Items | 204.09 | 218 | 284.73 | 297.29 | 178.16 | 173.82 |
Gain (Loss) on Sale of Assets | - | - | 0.7 | - | - | - |
Other Unusual Items | -0.18 | -0.18 | 4.23 | 0.01 | - | - |
Pretax Income | 203.91 | 217.82 | 289.67 | 297.31 | 178.16 | 173.82 |
Income Tax Expense | 35.83 | 38.06 | 51.61 | 59.54 | 38.3 | 32.13 |
Earnings From Continuing Operations | 168.08 | 179.76 | 238.06 | 237.76 | 139.86 | 141.69 |
Minority Interest in Earnings | -24.15 | -27.7 | -32.66 | -27.44 | -2.75 | -18.48 |
Net Income | 143.94 | 152.06 | 205.39 | 210.32 | 137.11 | 123.21 |
Net Income to Common | 143.94 | 152.06 | 205.39 | 210.32 | 137.11 | 123.21 |
Net Income Growth | -27.53% | -25.97% | -2.34% | 53.39% | 11.29% | 6.22% |
Shares Outstanding (Basic) | 40 | 40 | 40 | 40 | 40 | 40 |
Shares Outstanding (Diluted) | 40 | 40 | 40 | 40 | 40 | 40 |
Shares Change (YoY) | 0.31% | 0.05% | -0.00% | -0.08% | -0.07% | -0.02% |
EPS (Basic) | 3.61 | 3.81 | 5.14 | 5.27 | 3.43 | 3.09 |
EPS (Diluted) | 3.58 | 3.79 | 5.13 | 5.25 | 3.42 | 3.07 |
EPS Growth | -27.84% | -26.12% | -2.20% | 53.31% | 11.34% | 6.23% |
Free Cash Flow | 288.96 | 263.06 | 126.94 | 290.43 | 162.88 | 235.37 |
Free Cash Flow Per Share | 7.19 | 6.56 | 3.17 | 7.25 | 4.06 | 5.87 |
Dividend Per Share | 4.200 | 4.200 | 4.150 | 5.579 | 2.367 | 2.780 |
Dividend Growth | 1.21% | 1.21% | -25.61% | 135.72% | -14.87% | 5.72% |
Gross Margin | 44.04% | 44.09% | 40.01% | 37.84% | 35.03% | 34.49% |
Operating Margin | 13.25% | 13.70% | 15.58% | 16.85% | 12.26% | 15.60% |
Profit Margin | 10.44% | 10.96% | 13.06% | 13.20% | 10.62% | 11.98% |
Free Cash Flow Margin | 20.96% | 18.97% | 8.07% | 18.23% | 12.61% | 22.89% |
EBITDA | 271.68 | 281.94 | 344.8 | 353.33 | 221.05 | 214.53 |
EBITDA Margin | 19.71% | 20.33% | 21.92% | 22.17% | 17.11% | 20.87% |
D&A For EBITDA | 89.08 | 91.95 | 99.71 | 84.77 | 62.72 | 54.11 |
EBIT | 182.6 | 189.99 | 245.09 | 268.56 | 158.33 | 160.42 |
EBIT Margin | 13.25% | 13.70% | 15.58% | 16.85% | 12.26% | 15.60% |
Effective Tax Rate | 17.57% | 17.47% | 17.82% | 20.03% | 21.50% | 18.49% |